Solute Carrier Family 22 Member 18 (SLC22A18) Peptide
SLC22A18
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all ORCTL-2/SLC22A18 (SLC22A18) products
- ORCTL-2/SLC22A18 (SLC22A18) (Solute Carrier Family 22 Member 18 (SLC22A18))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- IQCPAILAAL ATLLGAVLSF TCIPASTKGA KTDAQAPLPG GPRASVFDLK
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC22 A18 antibody,
Alternative Names: SLC22A18 control peptide, SLC22A18 antibody Blocking Peptide, Anti-SLC22A18 Blocking Peptide, Solute Carrier Family 22 Member 18 Blocking Peptide, BWR1A Blocking Peptide, BWSCR1A Blocking Peptide, DKFZp667A184 Blocking Peptide, HET Blocking Peptide, IMPT1 Blocking Peptide, ITM Blocking Peptide, ORCTL2 Blocking Peptide, SLC22A1L Blocking Peptide, TSSC5 Blocking Peptide, p45-BWR1A Blocking Peptide, SLC22A18, SLCA18-22, SLCA18 22, SLCA18-22 Blocking Peptide, SLCA18 22 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ORCTL-2/SLC22A18 (SLC22A18) (Solute Carrier Family 22 Member 18 (SLC22A18))
- Background
- This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer.
- Molecular Weight
- 45 kDa
-
You are here:
